Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenue $ 26,877 $ 5,313 $ 49,344 $ 18,982
Cost of sales 18,318 3,949 33,316 11,372
Gross profit 8,559 1,364 16,028 7,610
Selling, general and administrative:        
Severance and transition costs 116 134 354 1,112
Acquisition related expenses 156 641 584 2,216
Amortization and depreciation 1,750 532 3,858 2,588
Stock based compensation 227 53 588 754
Other selling, general and administrative 6,560 2,557 16,562 6,922
Research and development 495 503 1,474 1,283
Total operating expenses 9,304 4,420 23,420 14,875
Operating loss (745) (3,056) (7,392) (7,265)
Non-operating income (expense):        
Change in fair value of embedded derivative       (6,990)
Gain on bargain purchase of business       743
Interest expense (192) (24) (651) (24)
Other income 29   11 3
Total non-operating expense, net (163) (24) (640) (6,268)
Loss before taxes (908) (3,080) (8,032) (13,533)
Deferred income tax (provision) benefit (496)   5,468  
Net loss (1,404) (3,080) (2,564) (13,533)
Accrual of preferred stock dividends (645) (358) (1,449) (951)
Accretion to redemption value of Series E, F and G preferred stock (6) (107) (919) (2,284)
Net loss attributable to common stockholders $ (2,055) $ (3,545) $ (4,932) $ (16,768)
Net loss per common share attributable to common stockholders-Basic and diluted $ (0.02) $ (0.04) $ (0.06) $ (0.22)
Weighted average shares outstanding-Basic and diluted 90,714 79,303 87,179 76,110